• Summit Therapeutics Chief Accounting Officer Bhaskar Anand received 100,000 common shares on October 8, 2026.
• The award brought his directly held shares to 261,047.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Summit Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001890784-26-000006), on October 14, 2026, and is solely responsible for the information contained therein.